Cargando…

Evaluation of low dose prazosin for PTSD-associated nightmares in children and adolescents

INTRODUCTION: Knowledge about fundamental sleep disorders and dysregulation that occurs in children with PTSD is limited. Prazosin is an alpha-1 receptor antagonist often used off label for the treatment of PTSD-associated nightmares in adults; however, evaluation of its use in pediatrics and adoles...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hudson, Nancy, Burghart, Steven, Reynoldson, Jill, Grauer, Dennis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	College of Psychiatric & Neurologic Pharmacists 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019540/ https://www.ncbi.nlm.nih.gov/pubmed/33850681 http://dx.doi.org/10.9740/mhc.2021.03.045

Ejemplares similares

Use of Prazosin for Pediatric PTSD-Associated Nightmares and Sleep Disturbances: A Retrospective Chart Review
por: Keeshin, Brooks R., et al.
Publicado: (2017)

Bedtime doses of prazosin do not affect daytime salivary amylase markers in PTSD
por: McCall, William Vaughn, et al.
Publicado: (2019)

Prazosin for Trauma Nightmares and Sleep Disturbances in Combat Veterans with Post-Traumatic Stress Disorder
por: Khazaie, Habibolah, et al.
Publicado: (2016)

Twice Daily Prazosin and Valproic Acid in the Treatment of Flashbacks in PTSD
por: Fisher, Kristy A., et al.
Publicado: (2022)

The Relative Effects of Prazosin on Individual PTSD Symptoms: Evidence for Pathophysiologically-Related Clustering
por: Hendrickson, Rebecca C., et al.
Publicado: (2021)

Case series: Continued remission of PTSD symptoms after discontinuation of prazosin
por: Richardson, Christie, et al.
Publicado: (2023)

Nightmares that mislead to diagnosis of reactivation of PTSD
por: Roepke, Stefan, et al.
Publicado: (2013)

Prazosin dosed 3 times a day to treat flashbacks related to PTSD: A case report
por: Richardson, Christie, et al.
Publicado: (2022)

Nightmares and Sleep Disturbances in Children with PTSD: A Polysomnographic and Actigraphy Approach Evaluation
por: Rolling, Julie, et al.
Publicado: (2023)

Disturbed Sleep in PTSD: Thinking Beyond Nightmares
por: Lancel, Marike, et al.
Publicado: (2021)

Use of Prazosin for Pediatric Post-Traumatic Stress Disorder With Nightmares and/or Sleep Disorder: Case Series of 18 Patients Prospectively Assessed
por: Ferrafiat, Vladimir, et al.
Publicado: (2020)

A Pilot Study on the Effectiveness of Prazosin as a Treatment of Post-Traumatic Stress Disorder-Related Nightmares in Women with Bulimia Nervosa
por: Mahr, Fauzia, et al.
Publicado: (2023)

Treating nightmares in PTSD with doxazosin: a report of three cases
por: Calegaro, Vitor Crestani, et al.
Publicado: (2019)

Effect of adrenergic blockers, carvedilol, prazosin, metoprolol and combination of prazosin and metoprolol on paracetamol-induced hepatotoxicity in rabbits
por: Zubairi, Maysaa B., et al.
Publicado: (2014)

Prazosin, Scorpion Sting and Dr. Bawaskar
por: Siva Sankara Murty, Yerramilli V.
Publicado: (2012)

Different neural circuitry is involved in physiological and psychological stress-induced PTSD-like “nightmares” in rats
por: Yu, Bin, et al.
Publicado: (2015)

Prazosin initiation and dose titration in a patient with posttraumatic stress disorder on concurrent carvedilol
por: Khaw, Chelsea, et al.
Publicado: (2019)

Prazosin inhibits the growth and mobility of osteosarcoma cells
por: An, Ming, et al.
Publicado: (2019)

Prazosin for the management of behavioural and psychological symptoms of dementia
por: Tampi, Rajesh R, et al.
Publicado: (2022)

Nightmare
por: Moore, William
Publicado: (1889)

Prazosin Can Prevent Glucocorticoid Mediated Capillary Rarefaction
por: Mandel, Erin R., et al.
Publicado: (2016)

Efficacy and safety of scorpion antivenom plus prazosin compared with prazosin alone for venomous scorpion (Mesobuthus tamulus) sting: randomised open label clinical trial
por: Bawaskar, Himmatrao Saluba, et al.
Publicado: (2011)

Controlling of Bacterial Virulence: Evaluation of Anti-Virulence Activities of Prazosin against Salmonella enterica
por: Elfaky, Mahmoud A., et al.
Publicado: (2022)

Prazosin during threat discrimination boosts memory of the safe stimulus
por: Homan, Philipp, et al.
Publicado: (2017)

PRESCRIBER'S NIGHTMARE
por: Shamasundar, C.
Publicado: (1992)

Dreams and nightmares
por: Hadfield, J. A. 1882-1967 (James Arthur)

Nightmares and hopes
por: Casimir, Hendrik Brugt Gerhard, et al.
Publicado: (1988)

Nightmare Abbey
por: Sharp, John Anthony 1915-

Nightmare and Dreaming
por: Winn, J. M.
Publicado: (1876)

The Physiology of Nightmare
por: Wooton, Edwin
Publicado: (1879)

Nightmares and the Cannabinoids
por: Mamelak, Mortimer
Publicado: (2020)

Nightmare frequency and nightmare distress: Socio-demographic and personality factors
por: Schredl, Michael, et al.
Publicado: (2019)

Low-Dose Mirtazapine-Induced Nightmares Necessitating its Discontinuation in a Young Adult Female
por: Menon, Vikas, et al.
Publicado: (2017)

Using Prazosin to Treat Posttraumatic Stress Disorder and Associations: A Systematic Review
por: Paiva, Henrique Soares, et al.
Publicado: (2021)

Clonidine Use for the Treatment of Nightmares in Posttraumatic Stress Disorder
por: Bange, Jill S., et al.
Publicado: (2022)

Nightmare experience and family relationships in healthy volunteers and nightmare disorder patients
por: Wang, Chu, et al.
Publicado: (2019)

A neurocomputational theory of nightmares: the role of formal properties of nightmare images
por: McNamara, Patrick, et al.
Publicado: (2021)

Psychometric evaluation of the Hamburg Nightmare Questionnaire (HNQ)
por: Gorzka, Robert-Jacek, et al.
Publicado: (2019)

Investigation of the Atypical Glass Transition and Recrystallization Behavior of Amorphous Prazosin Salts
por: Kumar, Lokesh, et al.
Publicado: (2011)

ODP032 Case Series: Prazosin in the Preoperative Management of Pheochromocytoma and Paraganglioma
por: Barreiro, Margarita, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a52tu16pj9lula6e79ckfth1a1